-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Provectus Biopharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q2 2024.
- Provectus Biopharmaceuticals, Inc. Operating Margin for the quarter ending June 30, 2024 was -374 %, a 8.11% decline year-over-year.
- Provectus Biopharmaceuticals, Inc. annual Operating Margin for 2023 was -520 %, a 50.1% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)